If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,644.00    22.00 (0.84%)
Bid:
2,639.00
Ask:
2,641.00
Spread: 2.00 (0.076%)
Market Cap: £23.49b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Transaction in Own Shares

10 Jun 2021 17:50

RNS Number : 5570B
Experian plc
10 June 2021
 

Transaction in Own Shares

 

 

10 June 2021 - Experian plc, the global information services company (the "Company"), hereby notifies the market, in conformity with Listing Rule 12.4.6R, of the following.

 

Further to the announcement by the Company on 19 May 2021 of a share repurchase programme, the Company announces that it has purchased its ordinary shares of 10 US cents each ("Shares") on the London Stock Exchange through Merrill Lynch International as follows:

 

Date and time of purchase: 10 June 2021 - 16.30

 

Number of Shares purchased (aggregate volume): 713

 

Lowest price per share: 2675.0000p

 

Highest price per share: 2675.0000p

 

Weighted average price: 2675.0000p

 

The Shares purchased will initially be held as treasury shares. Following this purchase, the Company holds 45,831,812 Shares in treasury. Since announcing the share repurchase programme, the Company has purchased 100,713 Shares. The total number of Shares in issue (excluding treasury shares) following this announcement is 923,793,183.

 

All transactions under this programme will be published on the Company's website (www.experianplc.com) on a weekly basis.

 

 

Contact:

 

Experian

Ronan Hanna Deputy Company Secretary +353 (0) 1 846 9128

 

About Experian

Experian is the world's leading global information services company. During life's big moments - from buying a home or a car, to sending a child to college, to growing a business by connecting with new customers - we empower consumers and our clients to manage their data with confidence. We help individuals to take financial control and access financial services, businesses to make smarter decisions and thrive, lenders to lend more responsibly, and organisations to prevent identity fraud and crime.

 

We have 17,800 people operating across 44 countries and every day we're investing in new technologies, talented people, and innovation to help all our clients maximise every opportunity. We are listed on the London Stock Exchange (EXPN) and are a constituent of the FTSE 100 Index.

 

Learn more at www.experianplc.com or visit our global content hub at our global news blog for the latest news and insights from the Group.

 

Neither the content of the Company's website, nor the content of any website accessible from hyperlinks on the Company's website (or any other website), is incorporated into, or forms part of, this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSDZGMVVGRGMZM
Date   Source Headline
11th Oct 20239:46 amRNSAdditional Listing
6th Oct 20233:30 pmRNSShare repurchase programme
4th Oct 20239:04 amRNSAdditional Listing
27th Sep 20235:07 pmRNSTransaction in Own Shares
27th Sep 20239:50 amRNSAdditional Listing
26th Sep 20235:08 pmRNSTransaction in Own Shares
25th Sep 20235:47 pmRNSTransaction in Own Shares
20th Sep 20239:13 amRNSAdditional Listing
19th Sep 20232:45 pmRNSBlock listing Interim Review
13th Sep 20239:30 amRNSAdditional Listing
31st Aug 202312:32 pmRNSTotal Voting Rights
30th Aug 20239:25 amRNSAdditional Listing
23rd Aug 20235:34 pmRNSTransaction in Own Shares
23rd Aug 20239:32 amRNSAdditional Listing
22nd Aug 20235:54 pmRNSTransaction in Own Shares
16th Aug 20239:16 amRNSAdditional Listing
9th Aug 20239:30 amRNSAdditional Listing
2nd Aug 20239:16 amRNSAdditional Listing
31st Jul 202312:05 pmRNSTotal Voting Rights
26th Jul 202310:00 amRNSAdditional Listing
25th Jul 20232:30 pmRNSDirector/PDMR Shareholding
25th Jul 202310:30 amRNSDirector/PDMR Shareholding
19th Jul 20232:32 pmRNSAdditional Listing
19th Jul 202312:22 pmRNSResult of AGM
13th Jul 20237:00 amRNSTrading update, first quarter
12th Jul 20239:30 amRNSHolding(s) in Company
11th Jul 20234:00 pmRNSHolding(s) in Company
6th Jul 20233:00 pmRNSHolding(s) in Company
30th Jun 20235:32 pmRNSSecond Interim Dividend
30th Jun 202310:30 amRNSTotal Voting Rights
28th Jun 202310:00 amRNSAdditional Listing
23rd Jun 202310:00 amRNSDirector/PDMR Shareholding
22nd Jun 202310:55 amRNSDirector/PDMR Shareholding
21st Jun 202311:00 amRNSAdditional Listing
14th Jun 202312:00 pmRNSAdditional Listing
14th Jun 202310:00 amRNSDirector/PDMR Shareholding
9th Jun 20234:00 pmRNSAnnual Financial Report
7th Jun 20233:49 pmRNSDirector/PDMR Shareholding
2nd Jun 20239:00 amRNSElections for second interim dividend
31st May 20231:12 pmRNSTotal Voting Rights
31st May 20239:32 amRNSAdditional Listing
22nd May 202312:46 pmRNSDirector/PDMR Shareholding
18th May 20232:29 pmRNSDirector/PDMR Shareholding
18th May 202310:20 amRNSDirector/PDMR Shareholding
17th May 20234:00 pmRNSDirector/PDMR Shareholding
17th May 202311:00 amRNSShare repurchases
17th May 20237:00 amRNSFull-year financial report
28th Apr 202310:15 amRNSTotal Voting Rights
12th Apr 20239:30 amRNSAdditional Listing
4th Apr 20239:45 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.